Expedited Patient-Centered
Outcome Measurement
Development for Cancer Care
October 15, 2015
Tracy Spinks, Program Director, Cancer Care Delivery and
Associate, Institute forCancer Care Innovation
Abstract Authors
• Tracy E. Spinks, Program Director, Cancer Care Delivery,The
University ofTexas MD Anderson Cancer Center
• Tinisha L. Mayo, Program Manager,The University ofTexas MD
Anderson Cancer Center
• Seohyun Lee, Graduate Research Assistant, The University ofTexas
MD Anderson Cancer Center
• ThomasW. Feeley, M.D., Head, Institute forCancer Care Innovation,
The University ofTexas MD Anderson Cancer Center
About MD Anderson
• Founded in 1941
• Part ofThe University ofTexas System
• National Cancer Institute-designated
Comprehensive CancerCenter
since 1971
• Multidisciplinary care since 1992
MD Anderson FY2014 Activity
Workforce
Employees
Faculty
Volunteers
Trainees
Clinical Activity
Number of patients 127,000
Number of hospital beds 654
Outpatient clinic visits,
treatments & procedures
1.36 MM
Financial Activity in USD
Revenue $4.4 BB
Research expenditures $736 MM
Uncompensated care $196 MM
About the Institute for Cancer Care Innovation
• Created in 2008
• Studies new and existing models of
cancer care delivery and reimbursement,
based on the principles of value-based
health care delivery
Research Priorities
BACKGROUND
Background
• Problem: providers, payers, and patients lack timely and
relevant outcomes information to:
– Support informed decision-making
– Make comparisons across providers and over time
• Intervention: develop patient-centered outcome measures
– Integrate data collection within new EPIC electronic health record
(EHR)
Project Aims
• Apply an expedited, patient-
centered approach to create
disease-specific outcome
measure sets for cancer care
• Establish routine outcomes data
collection, including patient-reported
outcomes (PRO), in the EHR
Disease-
Specific
Outcomes
MeasureSet
Patient-
Identified
Outcomes
(Focus
Groups)
Provider-
Identified
Outcomes
(Interviews)
METHODS
Michael Porter’s Outcome Measures Hierarchy
SOURCE Porter, M. E. (2010). What is value in health care? N Engl J Med, 363(26), 2477-2481. doi: 10.1056/NEJMp1011024.
Outcome Measure Development Considerations
• More measures <> better care
• Fewer, high-level measures
• Ideally, 5-10 outcomes per
disease site, including PROs
Important
to Patients/
High-Impact
Actionableby
Clinicians
Validated/
Evidence-Based Feasible
Measure
Criteria
Outcome Measure Development Process
• Measure set scope
• Outcome concepts
• Preliminary benchmarks
ConceptDevelopment
1month
MeasureSpecification
1-2months
• Detailed specifications
• Data sources
• Data collection
 Clinical workflow
 Patient flow
• Reporting mechanisms
• Internal validation
• Build design/testing/
implementation
 Interim system
 EHR (EPIC)
• Reporting design/
implementation
MeasureImplementation
6-12months
Incorporate patient perspective, where possible
RESULTS
• 6 outcome sets developed within 4-6 months
– 4 outcome sets deployed with new EHR (March
2016)
• By late-2016, 21 outcome sets in EHR
Results
6 Completed
Outcome Sets
 Breast
 Colorectal
 Head and Neck
 Lung (note)
 Pancreas
 Prostate (note)
NOTE We incorporated measure concepts developed by ICHOM for early-stage prostate cancer
and lung cancer into our outcome sets.
Sample Outcome Set—Head and Neck
SOURCE Adapted from Porter, M. E. (2010). What is value in health care? N EnglJ Med, 363(26), 2477-
2481. doi: 10.1056/NEJMp1011024.
Recurrences
Care-induced
Illnesses
Timely access, treatment start/completion
Reoperation Length of stay
Unplanned admission Mortality
Emergency visit
Tier 2
Process of
Recovery
Overall survival
Return to work/daily activities
Speaking, swallowing
Tier 1
Health status
achieved or
retained
PROs
Disease-free/disease-specific survival Recurrence
Dry mouth
Feeding or breathing tube
Cosmetic satisfaction
Tier 3
Sustainability
of health PROs
DISCUSSION
Discussion
• Patient-centered outcomes can be developed using an
expedite timeline
• Provider/leadership buy-in and strong project management
are essential
• Short-term IT solutions can expedite progress
Acknowledgements
• MD Anderson Cancer Center: Business AffairsAdministration;
Clinical Operations; Digital Experience; EHRAnalytics &
Reporting; Finance; Government Relations; Head and Neck
Center; Institute for Cancer Care Innovation; Office of the
EVP/Physician-in-Chief
• Harvard Business School Institute for Strategy and
Competitiveness
ThankYou
Contact Information
Tracy Spinks, Program Director, Cancer Care Delivery tespinks@mdanderson.org
Tinisha Mayo, Program Manager, Clinical Operations tlmayo@mdanderson.org
Seohyun Lee, Graduate Research Assistant SLee21@mdanderson.org
Thomas W. Feeley, M.D., Head, Institute for Cancer Care Innovation tfeeley@mdanderson.org

Expedited patient-centered outcome measurement development for cancer care

  • 2.
    Expedited Patient-Centered Outcome Measurement Developmentfor Cancer Care October 15, 2015 Tracy Spinks, Program Director, Cancer Care Delivery and Associate, Institute forCancer Care Innovation
  • 3.
    Abstract Authors • TracyE. Spinks, Program Director, Cancer Care Delivery,The University ofTexas MD Anderson Cancer Center • Tinisha L. Mayo, Program Manager,The University ofTexas MD Anderson Cancer Center • Seohyun Lee, Graduate Research Assistant, The University ofTexas MD Anderson Cancer Center • ThomasW. Feeley, M.D., Head, Institute forCancer Care Innovation, The University ofTexas MD Anderson Cancer Center
  • 4.
    About MD Anderson •Founded in 1941 • Part ofThe University ofTexas System • National Cancer Institute-designated Comprehensive CancerCenter since 1971 • Multidisciplinary care since 1992
  • 5.
    MD Anderson FY2014Activity Workforce Employees Faculty Volunteers Trainees Clinical Activity Number of patients 127,000 Number of hospital beds 654 Outpatient clinic visits, treatments & procedures 1.36 MM Financial Activity in USD Revenue $4.4 BB Research expenditures $736 MM Uncompensated care $196 MM
  • 6.
    About the Institutefor Cancer Care Innovation • Created in 2008 • Studies new and existing models of cancer care delivery and reimbursement, based on the principles of value-based health care delivery Research Priorities
  • 7.
  • 8.
    Background • Problem: providers,payers, and patients lack timely and relevant outcomes information to: – Support informed decision-making – Make comparisons across providers and over time • Intervention: develop patient-centered outcome measures – Integrate data collection within new EPIC electronic health record (EHR)
  • 9.
    Project Aims • Applyan expedited, patient- centered approach to create disease-specific outcome measure sets for cancer care • Establish routine outcomes data collection, including patient-reported outcomes (PRO), in the EHR Disease- Specific Outcomes MeasureSet Patient- Identified Outcomes (Focus Groups) Provider- Identified Outcomes (Interviews)
  • 10.
  • 11.
    Michael Porter’s OutcomeMeasures Hierarchy SOURCE Porter, M. E. (2010). What is value in health care? N Engl J Med, 363(26), 2477-2481. doi: 10.1056/NEJMp1011024.
  • 12.
    Outcome Measure DevelopmentConsiderations • More measures <> better care • Fewer, high-level measures • Ideally, 5-10 outcomes per disease site, including PROs Important to Patients/ High-Impact Actionableby Clinicians Validated/ Evidence-Based Feasible Measure Criteria
  • 13.
    Outcome Measure DevelopmentProcess • Measure set scope • Outcome concepts • Preliminary benchmarks ConceptDevelopment 1month MeasureSpecification 1-2months • Detailed specifications • Data sources • Data collection  Clinical workflow  Patient flow • Reporting mechanisms • Internal validation • Build design/testing/ implementation  Interim system  EHR (EPIC) • Reporting design/ implementation MeasureImplementation 6-12months Incorporate patient perspective, where possible
  • 14.
  • 15.
    • 6 outcomesets developed within 4-6 months – 4 outcome sets deployed with new EHR (March 2016) • By late-2016, 21 outcome sets in EHR Results 6 Completed Outcome Sets  Breast  Colorectal  Head and Neck  Lung (note)  Pancreas  Prostate (note) NOTE We incorporated measure concepts developed by ICHOM for early-stage prostate cancer and lung cancer into our outcome sets.
  • 16.
    Sample Outcome Set—Headand Neck SOURCE Adapted from Porter, M. E. (2010). What is value in health care? N EnglJ Med, 363(26), 2477- 2481. doi: 10.1056/NEJMp1011024. Recurrences Care-induced Illnesses Timely access, treatment start/completion Reoperation Length of stay Unplanned admission Mortality Emergency visit Tier 2 Process of Recovery Overall survival Return to work/daily activities Speaking, swallowing Tier 1 Health status achieved or retained PROs Disease-free/disease-specific survival Recurrence Dry mouth Feeding or breathing tube Cosmetic satisfaction Tier 3 Sustainability of health PROs
  • 17.
  • 18.
    Discussion • Patient-centered outcomescan be developed using an expedite timeline • Provider/leadership buy-in and strong project management are essential • Short-term IT solutions can expedite progress
  • 19.
    Acknowledgements • MD AndersonCancer Center: Business AffairsAdministration; Clinical Operations; Digital Experience; EHRAnalytics & Reporting; Finance; Government Relations; Head and Neck Center; Institute for Cancer Care Innovation; Office of the EVP/Physician-in-Chief • Harvard Business School Institute for Strategy and Competitiveness
  • 20.
    ThankYou Contact Information Tracy Spinks,Program Director, Cancer Care Delivery [email protected] Tinisha Mayo, Program Manager, Clinical Operations [email protected] Seohyun Lee, Graduate Research Assistant [email protected] Thomas W. Feeley, M.D., Head, Institute for Cancer Care Innovation [email protected]

Editor's Notes

  • #9 Fertility Preservation: How would a 34yo with newly diagnosed breast cancer find a medical oncologist with the highest rate of fertility preservation? Cost/Benefit: How would a 50yo with prostate cancer choose the best treatment to preserve his urinary function while minimizing his time away from work and out-of-pocket spending?
  • #10 Prostate Breast Lung Pancreas Head and Neck Colorectal
  • #14 claims data, face sheets, departmental research databases, patient-reported outcome instruments
  • #16 We have met with reps from at least 10 multidisciplinary centers to begin this process. Some centers have expedited data collection and have implemented the PRO for outcome development in their center now. For example, with the head and neck center we have implemented the MDASI H&N Survey via clinic station to be administered to all patients at baseline and follow up. The pancreas center has decided to collect outcomes via a FACT HEP survey using a redcap database. This database went live in January. They have collected data on 18 patients. The center currently collects PRO for all new patients at baseline consult, pre treatment, and post operative. Questions and frustrations from faculty. Clear hand off